1. EURO CTO CLUB
Toulouse 2018
CTO in post CABG patients
Emmanouil S. Brilakis, MD, PhD
Minneapolis Heart Institute
15.05 – 15.15
Saturday, September 15, 2018
2. EURO CTO CLUB
Toulouse 2018
Disclosure Statement of Financial Interest
• Consulting/speaker honoraria: Abbott Vascular, American
Heart Association (associate editor Circulation), Amgen,
Boston Scientific, CSI, Elsevier, GE Healthcare, Medtronic.
• Research support: Osprey, Regeneron, Siemens.
• Shareholder: MHI Ventures.
• Board of Directors: Cardiovascular Innovations Foundation
• Board of Trustees: Society of Cardiovascular Angiography
and Interventions
3. CTO PCI in prior CABG pts
1. Treat the native vessel instead of SVG*
2. Staged SVG revascularization
3. Strong support
4. Retrograde (triple injection)
5. Wire through tortuosity
6. Reaching the lesion
7. Meticulous lesion modification
8. Watch for perforations
4. CTO PCI in prior CABG pts
1. Treat the native vessel instead of SVG*
2. Staged SVG revascularization
3. Strong support
4. Retrograde (triple injection)
5. Wire through tortuosity
6. Reaching the lesion
7. Meticulous lesion modification
8. Watch for perforations
5. SVGs do not do well long-term
Median FU: 2.7 years
Brilakis et al. Lancet 2018
Target vessel failure
8. Candidate for redo CABG?
Need for additional revascularization? Corresponding native coronary lesion complex?
LIMA to LAD feasible?
Consider redo CABG
SVG lesion complex?
Able to treat native lesion?
Native lesion PCI SVG PCI*
yes no
yes
yes
no
no
yes
no
yes
yes no
SVG lesion 2018: the “future” is
now!
9. CTO PCI in prior CABG pts
1. Treat the native vessel instead of SVG*
2. Staged SVG revascularization
3. Strong support
4. Retrograde (triple injection)
5. Wire through tortuosity
6. Reaching the lesion
7. Meticulous lesion modification
8. Watch for perforations
19. Procedural time: 249 min
Fluoroscopy time: 97.3 min
AK Radiation: 2.776 Gray
Contrast volume: 149 ml
Final Result
Conclusions
• Native coronary artery PCI is
preferred to SVG PCI (esp after
SVG occlusion), if feasible
• Treating ISR CTOs: sub-stent
crossing, re-entry, and
crushing stents
• Balloon undilatable lesion:
subintimal crossing can
provide effective treatment
21. Candidate for redo CABG?
Need for additional revascularization? Corresponding native coronary lesion complex?
LIMA to LAD feasible?
Consider redo CABG
SVG lesion complex?
Able to treat native lesion?
Native lesion PCI SVG PCI*
yes no
yes
yes
no
no
yes
no
yes
yes no
SVG lesion 2018: the “future” is
now!
Staged
22. Initial Angiogram: New Severe Lesion Skip Portion SVG
Between “OM1” & OM2; Significant ostial LCx disease
23. Attempted Intervention SVG Skip:
Unable to cross lesion
Patient developed
CP/ distal flow OM1
Next step?
24. Emergent CT Coronary Angiogram!!!
Identified branch in question to be high
takeoff diagonal/ramus
Small contrast opacification proximally, small
lateral branch open
Occlusion ~20mm